Success Metrics

Clinical Success Rate
88.9%

Based on 16 completed trials

Completion Rate
89%(16/18)
Active Trials
13(23%)
Results Posted
13%(2 trials)
Terminated
2(4%)

Phase Distribution

Ph not_applicable
24
43%
Ph phase_2
1
2%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution25 total trials
Phase 2Efficacy & side effects
1(4.0%)
N/ANon-phased studies
24(96.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

84.2%

16 of 19 finished

Non-Completion Rate

15.8%

3 ended early

Currently Active

13

trials recruiting

Total Trials

56

all time

Status Distribution
Active(22)
Completed(16)
Terminated(3)
Other(15)

Detailed Status

Completed16
unknown15
Recruiting11
Not yet recruiting9
Active, not recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
56
Active
13
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (4.0%)
N/A24 (96.0%)

Trials by Status

unknown1527%
recruiting1120%
active_not_recruiting24%
not_yet_recruiting916%
terminated24%
withdrawn12%
completed1629%

Recent Activity

Clinical Trials (56)

Showing 20 of 56 trialsScroll for more
NCT05861375

Liver Biomarkers in Anorexia Nervosa

Completed
NCT06877026Not Applicable

FibroScan-Reproducibility and Repeatability Study

Completed
NCT07449377Not Applicable

Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department

Not Yet Recruiting
NCT06477146Phase 2

Milk Thistle Clinical Trial in Pediatric NAFLD

Recruiting
NCT06445335Not Applicable

Prevalence of NAFLD in T2DM Patients

Active Not Recruiting
NCT01796145Not Applicable

Fibroscan Study in HCC

Active Not Recruiting
NCT07222813Not Applicable

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Not Yet Recruiting
NCT07206004

Effect of Parenteral Support on FibroScan in Short Bowel Syndrome

Not Yet Recruiting
NCT06592820

Endoscopic Ultrasound Shear Wave Elastography Study

Recruiting
NCT07146815Not Applicable

PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

Completed
NCT06757348

Fatty Liver and Pancreatic Steatosis

Not Yet Recruiting
NCT06445361Not Applicable

Prevalence of NAFLD in T1DM Patients

Recruiting
NCT07042360

Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation

Recruiting
NCT06960863

Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma

Recruiting
NCT04807868

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

Recruiting
NCT06634160

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

Recruiting
NCT06739330

Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease

Recruiting
NCT06715189

Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

Not Yet Recruiting
NCT06601361

Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital

Not Yet Recruiting
NCT06456970

Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes

Not Yet Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
56